Echo Pharmaceuticals has developed a process for formulating and administering lipophilic active compounds. Cannabinoids have been formulated with our technology resulting in a valuable product with improved solubility and bioavailability.
Echo´s technology can be used to formulate your active pharmaceutical compound into a suitable administration form. Our patented processes are scalable and cost effective.
Echo Pharmaceuticals is also specialized in isolation and purification of delta-9-tetrahydrocannabinol (Δ9-THC) from Cannabis Sativa via proprietary knowledge. The isolation process takes place in a controlled laboratory environment. The techniques used are cost effective, scalable and can be applied to isolate other major cannabinoids.
Pure THC can be supplied in different quantities and degrees of purities. Echo Pharmaceuticals delivers cannabinoid products only to companies with the required licenses for controlled substance.
We have at our disposal a cleanroom facility to produce pre-clinical and clinical batches of active pharmaceutical ingredients according to cGMP guidelines.